Table 2.
Risk factors for site-specific cancers.
| Crude OR (95% CI) | Adjusted OR (95% CI) | |
|---|---|---|
| Vitamin D | ||
| No | 1.00 | 1.00 |
| Yes | 1.71 (1.52-1.92)*** | 1.51 (1.34-1.70)*** |
| Age, year | ||
| < 50 | 1.00 | 1.00 |
| 50-64 | 1.00 (0.98-1.02) | 0.92 (0.91-0.94)*** |
| 65+ | 1.00 (0.98-1.02) | 0.87 (0.85-0.89)*** |
| Gender | ||
| Women | 1.00 | 1.00 |
| Men | 1.00 (0.99-1.01) | 1.04 (1.02-1.05)*** |
| CCI score | ||
| 0 | 1.00 | 1.00 |
| 1-2 | 1.80 (1.76-1.83)*** | 1.80 (1.76-1.83)*** |
| 3-4 | 1.15 (1.12-1.19)*** | 1.25 (1.21-1.29)*** |
| 5+ | 0.80 (0.76-0.83)*** | 0.94 (0.89-0.99)* |
| Comorbidity | ||
| Hyperlipidemia | 1.14 (1.12-1.16)*** | 0.90 (0.88-0.91)*** |
| Hypertension | 1.25 (1.23-1.27)*** | 0.99 (0.97-1.01) |
| Sleep disorder | 1.30 (1.28-1.32)*** | 1.10 (1.08-1.11)*** |
| Anxiety | 1.21 (1.19-1.23)*** | 0.98 (0.96-0.99)* |
| Depression | 1.18 (1.15-1.21)*** | 0.99 (0.96-1.02) |
| Obesity | 1.28 (1.18-1.39)*** | 1.08 (0.99-1.18) |
| Alcoholism | 2.04 (1.94-2.14)*** | 1.88 (1.79-1.98)*** |
| Medicine | ||
| CV drug | 1.54 (1.52-1.56)*** | 1.39 (1.36-1.42)*** |
| Estrogen | 1.54 (1.33-1.78)*** | 1.35 (1.16-1.57)*** |
| Statin | 1.27 (1.24-1.29)*** | 1.06 (1.03-1.09)*** |
| NSAID | 2.50 (2.47-2.54)*** | 2.43 (2.39-2.47)*** |
* p<0.05, ** p<0.01, *** p<0.001.